| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1147.146 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1147.146/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1147.146 |
| Version | 20210609 |
| Status | active |
| Date | 2021-06-09T01:00:50-04:00 |
| Name | BleedingAtNonCriticalSite |
| Title | Bleeding at Non Critical Site |
| Realm | us |
| Authority | hl7 |
| Description | The intent of the measure that this value set was created for is focused on bleeding that is likely to be etiologically related to in-hospital use of pharmacoprophylaxis for venous thromboembolism. This concept of bleeding at non-critical sites is to count bleeding events that may result in a decrease in hemoglobin or transfusion, but do not lead to loss of important functions due to their anatomic location. |
| Purpose | (Clinical Focus: The purpose of this Grouped value set is to identify major bleeding events not involving a critical area or organ during an encounter.),(Data Element Scope: This value set may use a model element related to Diagnosis.),(Inclusion Criteria: Includes concepts that represent diagnoses that indicate new onset of bleeding not involving a critical area or organ.),(Exclusion Criteria: Excludes concepts that represent any bleeding diagnoses that involve critical areas or organs. Injury or traumatic causes of bleeding are excluded. Obstetric related bleeds are also excluded.) |
FHIR